Latest news
Neurocrine Biosciences, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:NBIX) 2026-08-07 - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 23:12:53 GMTNeurocrine’s Investigational Obesity Drug Targets Three Receptors - Stock TitanStock Titan · Fri, 07 Aug 2026 12:30:00 GMTNBIX260821P00170000 interactive stock chart | NBIX Aug 2026 170.000 put stock - Yahoo Finance AustraliaYahoo Finance Australia · Fri, 07 Aug 2026 02:59:19 GMTNBIX Aug 2026 170.000 put (NBIX260821P00170000) stock price, news, quote and history - Yahoo Finance AustraliaYahoo Finance Australia · Fri, 07 Aug 2026 02:26:07 GMTNeurocrine Biosciences (NBIX) CSO Jude Onyia makes bona fide stock gift - Stock TitanStock Titan · Wed, 05 Aug 2026 21:36:27 GMTNeurocrine (NBIX) Q2 2026 Earnings Call Transcript - The Globe and MailThe Globe and Mail · Tue, 04 Aug 2026 00:14:00 GMTNBIX Aug 2026 100.000 call (NBIX260821C00100000) interactive stock chart - Yahoo Finance UKYahoo Finance UK · Mon, 03 Aug 2026 12:43:18 GMTNBIX Aug 2026 175.000 put (NBIX260821P00175000) interactive stock chart - Yahoo Finance UKYahoo Finance UK · Mon, 03 Aug 2026 11:11:34 GMT